Previous classification systems by our group and others have used the concept of:
Neuropathy
Neuropathy + Deformity
Previous History of Ulceration or Amputation
As a paradigm of escalating risk. While this is a common sense approach and is based on previous evidence(1), recent data(2) suggest that vascular disease may be an important independent factor. While not part of the traditional pathway of neuropathy + repetitive stress = ulcer, vascular disease appears to play a significant role in risk for recurrence(3), hospitalization, and amputation.(4)
The evolution of risk now may be simplified to include (Figure 1):
Neuropathy +/- Deformity
Vascular Disease
Previous History of Ulceration of Amputation
This leads us to a new, slightly modified classification of risk (Figure 1).
Figure 1
1.Lavery LA, Armstrong DG, Vela SA, Quebedeaux TL, Fleischli JG. Practical Criteria for Screening Patients at High Risk for Diabetic Foot Ulceration. Arch Intern Med. 1998;158:158-162.
2.Lavery LA, Peters EJ, Williams JR, Murdoch DP, Hudson A, Lavery DC. Re-evaluating How We Classify the Diabetic Foot: Restructuring the International Working Group's Diabetic Foot Risk Classification. Diabetes Care. 2007.
3.Peters EJ, Armstrong DG, Lavery LA. Risk factors for recurrent diabetic foot ulcers: Site matters. Diabetes Care. 2007.
4.Lavery LA, Peters EJ, Armstrong DG. What are the most important interventions in preventing diabetic foot ulcers? International Wound Journal. 2008:In Press.
Foot Risk Classification, 2.0
Risk Group
Definition
Treatment Recommendations
Follow Up
0
No LOPS, no PAD
Patient Education
Annually (by generalist and/or
specialist)
1
LOPS ± deformity
Consider prescriptive or accommodative footwear.
Consider prophylactic surgery if deformity is not able to be safely accommodated in shoes. Continue patient education.
Every 3-6 months (by specialist)
2
PAD ± LOPS
Consider prescriptive or accommodative footwear.
Consider vascular consultation for combined follow-up.
Every 2-3 months (by specialist)
3
History of Ulcer or Amputation
Same as category 1.
Consider vascular consultation for combined follow-up if PAD present.
Every 1-2 months (by specialist)
Lavery, Armstrong, et al, Arch Intern Med, 1998
Lavery, et al, Diabetes Care, 2007
LOPS = loss of protective sensation
PAD = peripheral arterial disease
CLEAR is an active clinical research unit of the
Dr. William M. Scholl College of Podiatric Medicine at
Rosalind Franklin University of Medicine and Science.
Visit the University at www.rosalindfranklin.edu.
© 2007 CLEAR All Rights Reserved